Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Gross Profit | 2,480 | 2,760 | 2,880 | 3,100 | 2,340 |
| Operating Expenses | 4,410 | 4,320 | 4,710 | 5,440 | 4,510 |
| Operating Income | -4,410 | -4,320 | -4,710 | -5,440 | -4,510 |
| Pre-tax Income | -4,410 | -4,320 | -4,710 | -5,440 | -4,510 |
| Net Income Continuous | -4,410 | -4,320 | -4,710 | -5,440 | -4,510 |
| Net Income | $-4,410 | $-4,320 | $-4,710 | $-5,440 | $-4,510 |
| EBITDA(a) | $-3,630 | $-3,560 | $-3,540 | $-4,710 | $-4,200 |